Company intelligence / Profile preview

Northern RNA

Calgary, Alberta, Canadanorthernrna.com ↗

Ownership: Private
Employees: ~150
Development stage: Commercial

Overview

Northern RNA is a Canadian CDMO specializing in the end-to-end manufacturing of nucleic acid products such as mRNA, plasmid DNA, cap analogs, and novel lipids. The company provides GMP-compliant services from construct design through fill/finish and cold chain distribution. It does not have its own therapeutic pipeline but enables rapid development of vaccines and advanced therapeutics by supplying high-quality raw materials to biotech/pharma clients globally. Recent grants support expansion into large-scale lipid production to address global supply shortages.

Modalities: mRNA-based drugsPlasmid DNALipid nanoparticle delivery therapySynthetic oligonucleotideCap analogs (for mRNA)
Industry: Contract Manufacturing Organization

Partnerships

SyVento BioTech (collaboration on mRNA therapeutics)

Beyond the preview

Go deeper on Northern RNA.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Northern RNA.

Explore the full profile